Videos

The subcommittee heard testimony from three panels of doctors, pharmaceutical corporation administrators and public health experts on the prices of prescription drugs. The subcommittee…

The subcommittee met to discuss the issues surrounding development of a new cancer drug and the implications of its manufacturing by national drug companies. Recently it has been discovered…